Macro Group Pharmaceuticals (MCRO) has released its prospectus ahead of its highly anticipated IPO.
More Details🧐 The FRA approved Macro’s prospectus yesterday, January 23rd, 2022, for the listing of 45.8% of the company’s shares on the EGX.
The IPO price range will have an EGP 6.05/share ceiling, giving the company a market capitalization up to EGP 3.5 billion.
Over 13 million shares representing 5% of the offering size will be available for public subscription from January 24, 2022, to February 7, 2022.
The minimum public subscription order is 100 shares.
Why is this Important🤔 Macro Group is the cosmeceuticals industry leader with a market share of 23.1%, more than triple its closest competitor. Thndr will be hosting a webinar this Thursday to discuss the offering in more detail.